Jonathan W. Said, MD

Link to more PubMed publications >

1. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood. 2005; 105(1): 376-81.
2. Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Experimental hematology. 2005; 33(1): 53-61.
3. Takeuchi S, de Vos S, Takeuchi N, Fermin AC, Grogan TM, Seo H, Said JW, Koeffler HP Allelic loss during progression of follicular lymphoma. Leukemia research. 2004; 28(6): 567-9.
4. Tsukasaki K, Tanosaki S, DeVos S, Hofmann WK, Wachsman W, Gombart AF, Krebs J, Jauch A, Bartram, CR, Nagai K, Tomonaga M, Said JW, Koeffler HP Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. International journal of cancer. Journal international du cancer. 2004; 109(6): 875-81.
5. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer research. 2004; 64(6): 1987-96.
6. Kumagai, T Ikezoe, T Gui, D O'Kelly, J Tong, XJ Cohen, FJ, Said, JW, Koeffler, HP RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004; 10(4): 1508-20.

• uclahealth.org/pathology